ASP Isotopes Inc. ASPI
2.93
(0.02)
(0.68%)
as of 25 Sep
- Market cap
- $466.1M
- P/E
- 0.0×
Follow ASPI
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | 0.00 | 60.86 | 18.62 |
P/FCF ratio |
— | — | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | (27.97) | (67.07) | (24.88) |
P/B ratio |
— | — | 3.06 | 4.93 | 1.69 |
Price to Tangible BV |
— | — | 3.70 | 5.25 | 1.73 |
EV/Sales |
— | — | 0.00 | 54.70 | 13.36 |
EV/EBITDA |
— | — | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | (9.29) | (13.58) | (8.43) |
EV/FCF |
— | — | (6.50) | (8.08) | (6.72) |
Quick Ratio |
9.74 | 1.23 | 1.56 | 8.87 | 11.72 |
Current Ratio |
10.62 | 1.71 | 1.85 | 9.31 | 12.23 |
Net Debt/EBITDA |
0.80 | 0.32 | 0.45 | 0.99 | 1.98 |
Debt/Assets |
12.44% | 6.21% | 2.46% | 38.55% | 43.84% |
Debt/Equity |
0.15 | 0.08 | 0.04 | 0.71 | 0.83 |
Asset Turnover |
— | 0.00 | 0.02 | 0.07 | 0.08 |
Operating CF/Net income |
0.00 | 0.59 | 0.33 | 0.48 | 0.22 |
Capex/Depreciation |
0.00 | (61.61) | (62.33) | (24.14) | (5.05) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | (62.54%) | (113.70%) | (100.33%) | (111.50%) | |
| 0.00% | (50.36%) | (81.35%) | (57.62%) | (59.12%) | |
ROIC |
0.00% | (38.84%) | (86.43%) | (64.22%) | (25.32%) |
Return on Tangible Assets |
(44.16%) | (51.69%) | (104.74%) | (43.33%) | (43.70%) |
Average Days of Receivables |
— | — | 790.78 | 64.74 | 763.50 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 176.58% | 75.75% | 51.82% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 3,560.37% | 598.79% | 202.26% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.12 | 0.03 | 0.02 |
Share Based Compensation of Revenue |
— | 0.00% | 2,174.02% | 238.30% | 70.01% |
Graham Net Nets |
— | — | 0.03 | 0.09 | 0.37 |
Graham Number |
— | — | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | (28.16%) | (14.35%) | (40.00%) |
Free Cash Flow Yield |
— | — | (13.46%) | (11.13%) | (10.68%) |
Revenue per Share |
0.00 | 0.00 | 0.01 | 0.07 | 0.29 |
Operating CF per Share |
0.00 | (0.11) | (0.16) | (0.30) | (0.46) |
Capex per Share |
0.00 | (0.17) | (0.07) | (0.20) | (0.12) |
Free Cash Flow per Share |
0.00 | (0.28) | (0.23) | (0.50) | (0.57) |
Cash per Share |
0.09 | 0.09 | 0.24 | 1.11 | 4.02 |
Shareholders Equity per Share |
0.17 | 0.37 | 0.57 | 0.92 | 3.17 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.17 | 0.37 | 0.57 | 0.92 | 3.17 |
Free Cash Flow |
0.00 | (7.41) | (7.74) | (28.07) | (47.43) |
Working Capital |
2.92 | 1.37 | 4.84 | 58.69 | 367.22 |
Capital Expenditures |
0.00 | (4.47) | (2.33) | (11.37) | (9.65) |
Net Current Asset Value |
2.08 | 0.62 | 1.80 | 22.56 | 164.80 |
EV/EBIT |
— | — | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 5.38 | 2.74 | 0.40 |
Net Profit Margin |
0.00% | 0.00% | (3,761.25%) | (847.35%) | (734.17%) |
Price to Operating Income |
— | — | 0.00 | 0.00 | 0.00 |
| Other line items | |||||
Depreciation/Fixed assets |
0.00 | 0.01 | 0.00 | 0.02 | 0.06 |
Cash ROIC |
(30.37%) | (85.81%) | (58.82%) | (26.13%) | (8.75%) |
Accounts Receivable Turnover |
— | — | 0.00 | 4.95 | 0.94 |
Accounts Payable Turnover |
0.00 | 0.10 | 0.24 | 2.39 | 6.03 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 35.13 |
Average Days of Payables |
1,123.22 | 6,811.83 | 1,379.83 | 146.43 | 102.75 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 9.47 | 19.60 |
Average Receivables |
— | — | — | 0.84 | 25.31 |
Average Payables |
— | 0.71 | 1.23 | 1.07 | 3.39 |
Average Inventory |
— | — | — | — | 0.58 |
Average Assets |
— | 9.82 | 20.02 | 60.94 | 296.18 |
Average Common Equity |
— | 7.91 | 14.32 | 35.00 | 157.03 |
Columns are period end dates